Evidence map›Paper›PMID 42540018›Full record

ArticleExploration of targeted anti-tumor therapy2026

Makito Miyake, Yuki Oda, Nobutaka Nishimura, Sayuri Ohnishi, Kazuki Miyazaki, Takuto Shimizu, Takuya Owari, Kota Iida, Kiyohide Fujimoto

Abstract read
In one paragraph

Article in Exploration of targeted anti-tumor therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Makito MiyakeDepartment of Urology, Nara Medical University, Kashihara 634-8522, Japan.ORCID https://orcid.org/0000-0001-9503-7356
Yuki OdaDepartment of Urology, Nara Medical University, Kashihara 634-8522, Japan.ORCID https://orcid.org/0000-0003-3909-1133
Nobutaka NishimuraDepartment of Urology, Nara Medical University, Kashihara 634-8522, Japan.ORCID https://orcid.org/0009-0000-1150-1298
Sayuri OhnishiDepartment of Urology, Nara Medical University, Kashihara 634-8522, Japan.
Kazuki MiyazakiDepartment of Urology, Nara Medical University, Kashihara 634-8522, Japan.
Takuto ShimizuDepartment of Urology, Nara Medical University, Kashihara 634-8522, Japan.
Takuya OwariDepartment of Urology, Nara Medical University, Kashihara 634-8522, Japan.
Kota IidaDepartment of Urology, Nara Medical University, Kashihara 634-8522, Japan.
Kiyohide FujimotoDepartment of Urology, Nara Medical University, Kashihara 634-8522, Japan.ORCID https://orcid.org/0000-0003-1507-2464

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to evaluate the suitability of archival ureteroscopic (URS) biopsy specimens for fibroblast growth factor receptor 3 (

Indexed as

biomarkerFGFR3gene alterationimmunohistochemical stainingRNAupper urinary tract carcinomaurothelial carcinoma

Identifiers

PMID42540018
PMCPMC13424798

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.